Skip to Main Content

Paper Details

Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.
Sci Transl Med
57
2021
Bacterial sepsis, CD14, CD14+, CD14+ monocyte, CD14+ monocyte state, COVID-19, Cas9, HSPCs, IL-10, IL-6, MS1, MS1 cells, MS1 gene program, MS1 monocytes, SARS-CoV-2 infection, bacterial sepsis, healthy bone marrow hematopoietic stem and progenitor cells, hematopoietic progenitors, monocytes, myeloid cell compartment, patients, sepsis, synthetic RNA analog
Author NameAffiliation
Michael R FilbinBroad Institute of MIT and Harvard
Michael R FilbinMassachusetts General Hospital and Harvard Medical School
Alexandra-Chloé VillaniBroad Institute of MIT and Harvard
Alexandra-Chloé VillaniCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School
Rebecca M BaronBrigham and Women's Hospital and Harvard Medical School
Nir HacohenBroad Institute of MIT and Harvard, USA. nhacohen@broadinstitute.org.
Nir HacohenCenter for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Nir HacohenBroad Institute of MIT and Harvard, USA. nhacohen@broadinstitute.org.
Nir HacohenCenter for Cancer Research, Massachusetts General Hospital and Harvard Medical School
  • 1 - 9

Datasets

Release 1.2